CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company's product candidate is cretostimogene, an inve...
Leadership
Arthur Kuan
Chairman & CEO
Ambaw Bellete M.S.
President & COO
James M. DeTore
Chief Financial Officer
Joshua F. Patterson
General Counsel, Chief Compliance Officer & Secretary
Vijay Kasturi M.D.
Chief Medical Officer
Swapnil Bhargava Ph.D.
Chief Technical Officer
Amy Steele
Vice President of Finance & Administration
Sarah Connors
Vice President of Communications & Patient Advocacy
